TWEAK, a new member of the tumor necrosis factor (TNF) family, induces cell
death in some tumor cell Lines, but its physiological functions are largel
y unknown. In this study, we investigated the expression and function of TW
EAK in human peripheral blood mononuclear cells (PBMCs) by using newly gene
rated anti-human TWEAK mAbs. Although freshly isolated PBMCs expressed no d
etectable level of TWEAK on their surfaces, a remarkable TWEAK expression w
as rapidly observed on monocytes upon stimulation with interferon (IFN)-gam
ma but not with IFN-alpha or lipopolysaccharide. Cytotoxic activity of IFN-
gamma -stimulated monocytes against human squamous carcinoma cell line HSC3
was inhibited partially by anti-TWEAK mAb alone and almost completely by c
ombination with anti-TRAIL (TNF-related apoptosis-inducing ligand) mAb. The
se results revealed a novel pathway of monocyte cytotoxicity against tumor
cells that is mediated by TWEAK and potentiated by IFN-gamma.